| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 764.81B | 736.56B | 692.16B | 611.63B | 550.34B |
| Gross Profit | 275.30B | 261.01B | 239.83B | 216.07B | 185.80B |
| EBITDA | 187.97B | 171.26B | 159.14B | 149.08B | 123.82B |
| Net Income | 93.76B | 79.64B | 76.31B | 71.44B | 52.87B |
Balance Sheet | |||||
| Total Assets | 928.50B | 922.77B | 838.22B | 789.65B | 656.54B |
| Cash, Cash Equivalents and Short-Term Investments | 168.60B | 173.94B | 129.26B | 115.61B | 153.19B |
| Total Debt | 282.04B | 298.54B | 237.74B | 250.42B | 165.59B |
| Total Liabilities | 490.54B | 519.75B | 435.82B | 447.17B | 323.33B |
| Stockholders Equity | 434.04B | 399.53B | 399.01B | 339.36B | 330.50B |
Cash Flow | |||||
| Free Cash Flow | 123.54B | 92.48B | 64.20B | 55.16B | 55.56B |
| Operating Cash Flow | 130.20B | 142.28B | 118.90B | 98.14B | 84.59B |
| Investing Cash Flow | -47.59B | -53.42B | -61.19B | -130.55B | -20.52B |
| Financing Cash Flow | -87.31B | -47.58B | -44.92B | -8.00B | -13.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥865.21B | 18.91 | ― | 1.39% | 4.95% | 9.54% | |
69 Neutral | ¥7.47T | 16.45 | 15.02% | 0.68% | -8.58% | 83.16% | |
69 Neutral | ¥1.77T | 27.09 | ― | 1.48% | 42.98% | 48.88% | |
64 Neutral | $2.43T | 25.28 | 22.48% | 1.14% | 4.50% | 16.63% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $6.41T | 29.01 | 11.69% | 0.55% | 2.68% | 56.38% |
Nomura Research Institute reported solid growth for the nine months ended December 31, 2025, with revenue rising 6.0% year on year to ¥602.3 billion and operating profit climbing 16.0% to ¥118.8 billion, reflecting improved profitability. Profit attributable to owners of the parent increased 15.9% to ¥83.2 billion, while basic earnings per share reached ¥145.21, supported by a stronger balance sheet as equity attributable to owners of the parent rose to ¥501.7 billion and the equity ratio improved to 52.9%. The company maintained its previously announced guidance for the full fiscal year ending March 31, 2026, projecting revenue of ¥810.0 billion and profit attributable to owners of the parent of ¥104.0 billion, and also affirmed its dividend outlook, targeting a higher annual dividend of ¥74.00 per share compared with ¥63.00 in the prior fiscal year, signaling confidence in earnings growth and shareholder returns.
The most recent analyst rating on (JP:4307) stock is a Buy with a Yen7000.00 price target. To see the full list of analyst forecasts on Nomura Research Institute stock, see the JP:4307 Stock Forecast page.